1. Home
  2. RVMD vs ELPC Comparison

RVMD vs ELPC Comparison

Compare RVMD & ELPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • ELPC
  • Stock Information
  • Founded
  • RVMD 2014
  • ELPC 1954
  • Country
  • RVMD United States
  • ELPC Brazil
  • Employees
  • RVMD N/A
  • ELPC N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • ELPC Electric Utilities: Central
  • Sector
  • RVMD Health Care
  • ELPC Utilities
  • Exchange
  • RVMD Nasdaq
  • ELPC Nasdaq
  • Market Cap
  • RVMD 7.5B
  • ELPC 6.1B
  • IPO Year
  • RVMD 2020
  • ELPC N/A
  • Fundamental
  • Price
  • RVMD $37.81
  • ELPC $7.43
  • Analyst Decision
  • RVMD Strong Buy
  • ELPC
  • Analyst Count
  • RVMD 13
  • ELPC 0
  • Target Price
  • RVMD $68.38
  • ELPC N/A
  • AVG Volume (30 Days)
  • RVMD 3.3M
  • ELPC 5.0K
  • Earning Date
  • RVMD 08-06-2025
  • ELPC 01-01-0001
  • Dividend Yield
  • RVMD N/A
  • ELPC 5.03%
  • EPS Growth
  • RVMD N/A
  • ELPC 31.95
  • EPS
  • RVMD N/A
  • ELPC 0.17
  • Revenue
  • RVMD N/A
  • ELPC $4,033,509,015.00
  • Revenue This Year
  • RVMD N/A
  • ELPC N/A
  • Revenue Next Year
  • RVMD $226.82
  • ELPC $5.55
  • P/E Ratio
  • RVMD N/A
  • ELPC $11.91
  • Revenue Growth
  • RVMD N/A
  • ELPC 6.92
  • 52 Week Low
  • RVMD $29.17
  • ELPC $5.04
  • 52 Week High
  • RVMD $62.40
  • ELPC $8.87
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 46.33
  • ELPC 34.41
  • Support Level
  • RVMD $36.37
  • ELPC $7.32
  • Resistance Level
  • RVMD $38.97
  • ELPC $8.47
  • Average True Range (ATR)
  • RVMD 1.34
  • ELPC 0.19
  • MACD
  • RVMD 0.07
  • ELPC -0.13
  • Stochastic Oscillator
  • RVMD 37.26
  • ELPC 9.17

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

About ELPC Companhia Paranaense de Energia (COPEL) (each representing four (4))

Cia Paranaense De Energia Copel is engaged in the areas of generation, transmission, commercialization and distribution of energy. It operates a comprehensive and effective electrical system with its own generating plants, transmission lines, substations, electrical lines and grids of the distribution system. The company's reportable segments include Power generation and transmission, Power distribution, GAS, Power sale, Services, and Holding. The majority of its revenue is generated from the Power generation and transmission segment under which it produces electricity from hydraulic, wind, and thermal projects and provides services of transmission and transformation of electric power and other related services.

Share on Social Networks: